Совместимость Берета и Феломика
Страница описания препарата Берета
Страница описания препарата Феломика
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study
Ther Drug Monit /Volume:33 Part:1/Feb Page:120-3 / 2011 / Kiberd BA, Wrobel M, Dandavino R et al
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil
Rheumatology (Oxford) /Volume:49 Part:11/Nov Page:2061-7 / 2010 / Schaier M, Scholl C, Scharpf D et al
Proton pump inhibitor co-medication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil
Transplant Proc /Volume:42 Part:10/Dec Page:4243-6 / 2010 / Doesch AO, Mueller S, Konstandin M et al
Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers
J Clin Pharmacol /Volume:52 Part:8/Aug Page:1265-72 / 2012 / Kees MG, Steinke T, Moritz S et al
Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation
Ther Drug Monit /Volume:30 Part:1/Feb Page:46-51 / 2008 / Miura M, Satoh S, Inoue K et al
The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients
J Heart Lung Transplant /Volume:30 Part:5/May Page:565-71 / 2011 / Kofler S, Wolf C, Shvets N et al
Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers
J Clin Pharmacol /Volume:49 Part:10/Oct Page:1196-201 / 2009 / Rupprecht K, Schmidt C, Raspé A et al